Loading the company…
Loading the company…
Families: Hysterectomy, hysteroscopy & ablation.
All companies · Product and company coverage
In 2025, Channel Medsystems reported engagement with 431 surgeons and other clinicians in the states MedaRep covers, worth $135K in consulting, speaking, meals and travel for its device products, the most in California ($95K to 3). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($95K, 3 engaged), North Carolina ($15K, 35 engaged), New York ($7,852, 12 engaged), Florida ($3,834, 80 engaged), Michigan ($3,672, 73 engaged).
In the last ten years FDA made 24 decisions for Channel Medsystems (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2021 (7). The latest was on 2026-09-15.
| Family | Decisions on record |
|---|---|
| Hysterectomy, hysteroscopy & ablation | 24 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-15 | PMA | P180032-S024 | Cerene® Cryotherapy Device · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2026-07-08 | PMA | P180032-S023 | Cerene® Cryotherapy Device · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2025-12-18 | PMA | P180032-S022 | Cerene® Cryotherapy Device · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-12-12 | PMA | P180032-S020 | Cerene Cryotherapy Device · Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| 2024-11-22 | PMA | P180032-S019 | Cerene Cryotherapy Device · Change Design/Components/Specifications/Material |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Channel Medsystems.